Published in Mater Sociomed on January 01, 2011
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med (2009) 17.17
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med (2009) 13.42
A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med (2009) 12.15
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet (1994) 11.37
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med (2008) 9.25
On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med (2009) 8.85
Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet (2011) 8.49
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med (2010) 7.39
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA (2009) 6.80
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet (2008) 6.41
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. JAMA (2011) 6.39
Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med (2010) 6.37
Drug-eluting versus bare-metal stents in large coronary arteries. N Engl J Med (2010) 5.43
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet (2010) 4.87
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. N Engl J Med (2010) 4.73
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial. Circulation (2009) 4.61
Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33
NICE guidance. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Heart (2010) 3.90
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet (2009) 3.55
Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med (2011) 3.55
Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial. JAMA (2010) 3.40
Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J (2011) 3.29
The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography. J Am Coll Cardiol (2010) 3.29
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med (2010) 3.27
Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med (2010) 2.92
Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med (2010) 2.90
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol (2010) 2.89
Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol (2010) 2.86
Coronary revascularization trends in the United States, 2001-2008. JAMA (2011) 2.81
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med (2011) 2.65
Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation (2010) 2.64
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial. Lancet (2010) 2.38
A randomized comparison of transradial versus transfemoral approach for coronary angiography and angioplasty. JACC Cardiovasc Interv (2009) 2.34
Assessment of the SYNTAX score in the Syntax study. EuroIntervention (2009) 2.24
No major differences in 30-day outcomes in high-risk patients randomized to off-pump versus on-pump coronary bypass surgery: the best bypass surgery trial. Circulation (2010) 2.21
Simple versus complex stenting strategy for coronary artery bifurcation lesions in the drug-eluting stent era: a meta-analysis of randomised trials. Heart (2009) 2.17
Long-term cardiovascular mortality after radiotherapy for breast cancer. J Am Coll Cardiol (2011) 2.14
Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry. J Am Coll Cardiol (2009) 2.12
Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol (2009) 2.10
Calcium-channel blockers reduce the antiplatelet effect of clopidogrel. J Am Coll Cardiol (2008) 2.10
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation (2009) 2.09
Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry. Circ Cardiovasc Interv (2009) 2.03
Randomized comparison of percutaneous coronary intervention with sirolimus-eluting stents versus coronary artery bypass grafting in unprotected left main stem stenosis. J Am Coll Cardiol (2011) 1.98
Economic evaluation of fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. Circulation (2010) 1.92
Meta-analysis of randomised trials comparing the effectiveness of miniaturised versus conventional cardiopulmonary bypass in adult cardiac surgery. Heart (2009) 1.91
Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med (2010) 1.89
Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA (2011) 1.88
Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85
Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart (2010) 1.81
Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation (2011) 1.75
Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med (2010) 1.70
EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart (2008) 1.63
The antiplatelet effect of aspirin is reduced by proton pump inhibitors in patients with coronary artery disease. Heart (2009) 1.62
Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med (2010) 1.62
Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition. Heart (2009) 1.60
Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results. Heart (2009) 1.55
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. J Am Coll Cardiol (2010) 1.51
Cognitive outcomes after on- versus off-pump coronary artery bypass surgery. Ann Thorac Surg (2010) 1.50
Universal definition of myocardial infarction. Heart (2008) 1.46
Dual antiplatelet therapy for more than 12 months after percutaneous coronary intervention: insights from the Guthrie PCI Registry. Heart (2009) 1.42
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM (2009) 1.17
Prognostic value of coronary revascularisation-related myocardial injury: a cardiac magnetic resonance imaging study. Heart (2009) 1.14
Sustained inflammation due to nuclear factor-kappa B activation in irradiated human arteries. J Am Coll Cardiol (2010) 1.10
Radial artery anomaly and its influence on transradial coronary procedural outcome. Heart (2008) 1.10
Delays in filling clopidogrel prescription after hospital discharge and adverse outcomes after drug-eluting stent implantation: implications for transitions of care. Circ Cardiovasc Qual Outcomes (2010) 1.03
Major improvement of percutaneous cardiovascular procedure outcomes with radial artery catheterisation: results from the PREVAIL study. Heart (2008) 0.98
Long-term benefit-risk balance of drug-eluting vs. bare-metal stents in daily practice: does stent diameter matter? Three-year follow-up of BASKET. Eur Heart J (2008) 0.97
Left ventricular assist devices. Heart (2009) 0.96
Three-year follow-up in a subset of high-risk patients randomly assigned to off-pump versus on-pump coronary artery bypass surgery: the Best Bypass Surgery trial. Heart (2011) 0.96
Underestimating medical therapy for coronary disease... again. N Engl J Med (2011) 0.95
ACE inhibitors for patients with vascular disease without left ventricular dysfunction--may they rest in PEACE? N Engl J Med (2004) 0.92
The effectiveness and cost-effectiveness of biomarkers for the prioritisation of patients awaiting coronary revascularisation: a systematic review and decision model. Health Technol Assess (2010) 0.91
Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five Registry. Heart (2010) 0.90
High residual platelet reactivity after clopidogrel loading and long-term clinical outcome after drug-eluting stenting for unprotected left main coronary disease. Circulation (2009) 0.89
Computed tomography versus exercise electrocardiography in patients with stable chest complaints: real-world experiences from a fast-track chest pain clinic. Heart (2009) 0.88
Prognosis of patients with ischaemic cardiomyopathy after coronary revascularisation: relation to viability and improvement in left ventricular ejection fraction. Heart (2009) 0.87
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 0.82
Five year prognosis in patients with angina identified in primary care: incident cohort study. BMJ (2009) 0.81
Long-term effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis results of the TRUE (Tuscany Registry of sirolimus for unselected in-stent restenosis) registry at 4 years. J Am Coll Cardiol (2010) 0.80
Emergence of the concept of platelet reactivity monitoring of response to thienopyridines. Heart (2009) 0.79
NT-proBNP and circulating inflammation markers in prediction of a normal myocardial scintigraphy in patients with symptoms of coronary artery disease. PLoS One (2010) 0.78
Clinical outcome of coronary stenting after thoracic radiotherapy: a case-control study. Heart (2010) 0.78
Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER). Int J Epidemiol (2012) 2.75
Ethnic differences in invasive management of coronary disease: prospective cohort study of patients undergoing angiography. BMJ (2002) 2.46
Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease. PLoS Med (2010) 1.89
Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER self-controlled case series study. J Infect Dis (2012) 1.73
Incremental prognostic value of the exercise electrocardiogram in the initial assessment of patients with suspected angina: cohort study. BMJ (2008) 1.64
Treatment paradigms in heart failure. Hosp Med (2002) 1.42
Clinical outcomes after myocardial revascularization according to operator training status: cohort study of 22,697 patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. Eur Heart J (2013) 1.40
Presentation of stable angina pectoris among women and South Asian people. CMAJ (2008) 1.01
Threshold haemoglobin levels and the prognosis of stable coronary disease: two new cohorts and a systematic review and meta-analysis. PLoS Med (2011) 0.99
Hemoglobin concentration is an independent determinant of heart failure in acute coronary syndromes: cohort analysis of 2310 patients. Am Heart J (2006) 0.97
Ethnic differences in long-term improvement of angina following revascularization or medical management: a comparison between south Asians and white Europeans. J Public Health (Oxf) (2008) 0.94
South Asians and coronary disease: is there discordance between effects on incidence and prognosis? Heart (2013) 0.93
Renal function and risk stratification in acute coronary syndromes. Am J Cardiol (2003) 0.92
Effect of patient-specific ratings vs conventional guidelines on investigation decisions in angina: Appropriateness of Referral and Investigation in Angina (ARIA) Trial. Arch Intern Med (2007) 0.88
Safety and feasibility of hospital discharge 2 days following primary percutaneous intervention for ST-segment elevation myocardial infarction. Heart (2012) 0.86
Success of a multidisciplinary heart failure clinic for initiation and up-titration of key therapeutic agents. Eur J Heart Fail (2005) 0.84
Almanac 2011: stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology. Heart (2011) 0.82
Prolonged hospital stay after acute myocardial infarction: assessing the evidence. Lancet (2004) 0.81
Rapid access chest pain clinics: are they clinically effective? Hosp Med (2003) 0.79
A statement on ethics from the HEART Group. JACC Cardiovasc Imaging (2008) 0.78
Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coron Artery Dis (2014) 0.78
Treading carefully: a qualitative ethnographic study of the clinical, social and educational uses of exercise ECG in evaluating stable chest pain. BMJ Open (2012) 0.78
Almanac 2011: Acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology. Heart (2011) 0.76
Risk assessment after acute coronary syndrome. BMJ (2006) 0.75
Almanac 2011: Acute Coronary Syndromes. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology. Mater Sociomed (2011) 0.75
Patients with cardiac chest pain should call emergency services. BMJ (2007) 0.75
[Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology]. G Ital Cardiol (Rome) (2012) 0.75
Almanac 2011: stable coronary artery disease. The national society journals present selected research that has driven recent advances in clinical cardiology. Turk Kardiyol Dern Ars (2011) 0.75
Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology. Turk Kardiyol Dern Ars (2011) 0.75
Acute coronary syndromes. Arch Cardiol Mex (2011) 0.75
Underuse of thrombolytic therapy in acute myocardial infarction and left bundle branch block. Clin Cardiol (2010) 0.75
Limited clinical utility of Holter monitoring in patients with palpitations or altered consciousness: analysis of 8973 recordings in 7394 patients. Ann Noninvasive Electrocardiol (2008) 0.75
Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study. Catheter Cardiovasc Interv (2012) 0.75
Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort. Am J Cardiol (2013) 0.75
The impact of socio-economic status on all-cause mortality after percutaneous coronary intervention: an observational cohort study of 13,770 patients. EuroIntervention (2015) 0.75
Stable coronary artery disease. The National Society Journals present selected research that has driven recent advances in clinical cardiology. Arch Cardiol Mex (2011) 0.75
[Almanac 2011: Stable coronary artery disease. An editorial overview of selected research that has driven recent advances in clinical cardiology]. G Ital Cardiol (Rome) (2012) 0.75
Almanac 2011: acute coronary syndromes. The national society journals present selected research that has driven recent advances in clinical cardiology. Rev Port Cardiol (2011) 0.75
National Society Cardiovascular Journals of Europe: Almanac 2011. Med Arh (2012) 0.75